Cecilia Nisticò

2.5k citations
70 papers · 1.6k indexed · h-index 23
Topics
Cancer Treatment and Pharmacology (44 papers)Breast Cancer Treatment Studies (34 papers)HER2/EGFR in Cancer Research (23 papers)

In The Last Decade

Cecilia Nisticò

65 papers receiving 1.6k citations

Peers

Cecilia Nisticò
Comparison fields: 5 of 85
  • Oncology 1.2k
  • Cancer Research 555
  • Pulmonary and Respiratory Medicine 403
  • Molecular Biology 306
  • Genetics 228
Replace Paola Papaldo with:
Paola Papaldo Italy
Deolinda Pereira Portugal
G. Peruzzotti Italy
Volker Möbus Germany
Peter Ang Singapore
Massimo Lopez Italy
Linnea Chap United States
H. Hausmaninger Austria
Giorgio Cocconi Italy
Akihiko Shimomura Japan
Cecilia Nisticò relative to Paola Papaldo Italy Paola Papaldo's profile →
Citations per field
00.5×1.7×
Paola Papaldo · 1×
Citations per year

Countries citing papers authored by Cecilia Nisticò

Since Specialization
Citations

This map shows the geographic impact of Cecilia Nisticò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Nisticò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Nisticò more than expected).

Fields of papers citing papers by Cecilia Nisticò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Nisticò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Nisticò. The network helps show where Cecilia Nisticò may publish in the future.

Co-authorship network of co-authors of Cecilia Nisticò

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Nisticò. A scholar is included among the top collaborators of Cecilia Nisticò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Nisticò. Cecilia Nisticò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 10
3 20
4 0
5 14
6 72
7 86
8 47
9 12
10 87
11 15
12 6
13 9
14 21
15 16
16 30
17 17
18 28
19 14
20 16

About Cecilia Nisticò

Cecilia Nisticò is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (44 papers), Breast Cancer Treatment Studies (34 papers) and HER2/EGFR in Cancer Research (23 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (555 citations) and Pulmonary and Respiratory Medicine (403 citations). Cecilia Nisticò has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include E. Terzoli, Diana Giannarelli, Francesco Cognetti, Emilio Bria, Federica Cuppone, Michèle Milella, Paolo Carlini, Isabella Sperduti, Alessandra Fabi and G. Ferretti. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026